Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Liver"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 86131
Tytuł:
Suppression of FOXO1 attenuates inflamm-aging and improves liver function during aging.
Autorzy:
Yang W; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Kim DM; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Jiang W; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Ai W; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Pan Q; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Rahman S; Department of Statistics, Texas A&M University, College Station, Texas, USA.
Cai JJ; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, USA.
Brashear WA; High Performance Research Computing, Texas A&M University, College Station, Texas, USA.
Sun Y; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Guo S; Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2023 Oct; Vol. 22 (10), pp. e13968. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Fatty Liver*/metabolism
Glucose Intolerance*/metabolism
Animals ; Mice ; Inflammation/metabolism ; Kupffer Cells/metabolism ; Liver/metabolism ; Macrophages/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma.
Autorzy:
Sharpton S; Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.
Shan K; Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.
Bettencourt R; Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.
Lee M; Department of Epidemiology, Genetics and Environmental Sciences, University of Texas School of Public Health, Brownsville, Texas, USA.
McCormick JB; Department of Epidemiology, Genetics and Environmental Sciences, University of Texas School of Public Health, Brownsville, Texas, USA.
Fisher-Hoch SP; Department of Epidemiology, Genetics and Environmental Sciences, University of Texas School of Public Health, Brownsville, Texas, USA.
Loomba R; Department of Medicine, NAFLD Research Center, University of California, San Diego, La Jolla, California, USA.; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.; Department of Family Medicine and Public Health, Division of Epidemiology, University of California, San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (4), pp. 378-386. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/complications
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/complications
Liver Neoplasms*/epidemiology
Liver Neoplasms*/genetics
Liver Neoplasms*/complications
Elasticity Imaging Techniques*
Adult ; Humans ; Female ; Middle Aged ; Male ; Mexican Americans/genetics ; Cohort Studies ; Prospective Studies ; Prevalence ; Cross-Sectional Studies ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/genetics ; Liver Cirrhosis/diagnosis ; Liver/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
Autorzy:
Eguchi A; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.
Iwasa M; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.
Nakagawa H; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Feb; Vol. 43 (2), pp. 292-298. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/etiology
Liver Diseases, Alcoholic*/complications
Extracellular Vesicles*/metabolism
Humans ; Hepatocytes/metabolism ; Liver Cirrhosis/complications ; Biomarkers/metabolism ; Liver/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
Autorzy:
Liu AN; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xu CF; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu YR; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun DQ; Department of Nephrology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.; Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Jiang L; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tang LJ; NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhu PW; Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chen SD; Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Liu WY; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang XD; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.
Targher G; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy.
Byrne CD; Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton & University of Southampton, Southampton General Hospital, Southampton, UK.
Wong VW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Fu J; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Su MM; Clinical Mass Spectrometry Innovation Center, Shanghai Keyi Biotechnology Co., Ltd., Shanghai, China.
Loomba R; NAFLD Research Center, Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
Zheng MH; NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China.
Ni Y; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 872-885. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Adult ; Male ; Humans ; Female ; Bile Acids and Salts ; Liver Cirrhosis/complications ; Inflammation/complications ; Biomarkers ; Obesity/complications ; Liver/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases.
Autorzy:
Hinkson A; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Lally H; School of Medicine, University of Leeds, Leeds, UK.
Gibson H; School of Medicine, University of Leeds, Leeds, UK.
Jones R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Rowe IA; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Shinkins B; Test Evaluation Group, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
Parker R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 750-762. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Meta-Analysis; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*
Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Liver/pathology ; Liver Function Tests ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
Autorzy:
Magherman L; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Parys R; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pauwels NS; Knowledge Center for Health Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.
Verhelst X; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Devisscher L; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Vlierberghe H; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Geerts A; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Lefere S; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 820-836. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*/etiology
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Alcohol Drinking/adverse effects ; Cross-Sectional Studies ; Fibrosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PTTG1 alleviates acute alcoholic liver injury by inhibiting endoplasmic reticulum stress-induced hepatocyte pyroptosis.
Autorzy:
Tien S; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Zhou H; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Zhou Q; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Liu H; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Wu B; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Guo Y; Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Apr; Vol. 43 (4), pp. 840-854. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Chemical and Drug Induced Liver Injury, Chronic*/pathology
Liver Neoplasms*/pathology
Mice ; Animals ; Pyroptosis ; Hepatocytes/metabolism ; Liver ; Ethanol/toxicity ; Endoplasmic Reticulum Stress ; Inflammation/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Autorzy:
Hamill V; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.; Public Health Scotland, Glasgow, UK.
Gelson W; Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
MacDonald D; Gastroenteology and Hepatology, Royal Free London NHS Foundation Trust, London, UK.
Richardson P; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Ryder SD; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.
Aldersley M; Leeds Liver Unit, St James's University Hospital, Leeds, UK.
McPherson S; Newcastle Liver Unit, Freeman Hospital, Newcastle upon Tyne, UK.
Verma S; Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.; Department of Gastroenterology and Hepatology, University Hospital Sussex NHS Foundation Trust, Brighton, UK.
Sharma R; Imperial College London, London, UK.
Hutchinson S; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.; Public Health Scotland, Glasgow, UK.
Benselin J; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.
Barnes E; Nuffield Department of Medicine and the Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Guha IN; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Irving WL; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, UK.
Innes H; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.; Public Health Scotland, Glasgow, UK.; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Apr; Vol. 43 (4), pp. 917-927. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/epidemiology
Liver Neoplasms*/therapy
Hepatitis C*/complications
Hepatitis C*/epidemiology
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/diagnostic imaging
Hepatitis C, Chronic*/drug therapy
Humans ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/therapy ; Hepacivirus ; United Kingdom/epidemiology ; Antiviral Agents/therapeutic use ; Sustained Virologic Response
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers.
Autorzy:
Hagström H; Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Yan J; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Talbäck M; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Andreasson A; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Psychology, Stress Research Institute, Stockholm University, Stockholm, Sweden.
Walldius G; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Hammar N; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (4), pp. 418-425. Date of Electronic Publication: 2022 Dec 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis*/epidemiology
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Biomarkers ; Diabetes Mellitus ; Follow-Up Studies ; gamma-Glutamyltransferase ; Liver/pathology ; Retrospective Studies ; Risk Assessment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis.
Autorzy:
Younossi Z; Inova Medicine, Inova Health System, Falls Church, Virginia, USA.; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
Alkhouri N; Arizona Liver Health, Chandler, Arizona, USA.
Cusi K; Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA.
Isaacs S; Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia, USA.
Kanwal F; Baylor College of Medicine, Michael E.D. Bakey VA Medical Center, Houston, Texas, USA.
Noureddin M; Fatty Liver Program at Cedars-Sinai Medical Center, West Hollywood, California, USA.
Loomba R; NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, California, USA.
Ravendhran N; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Lam B; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
Nader K; George Washington Medical Faculty Associates, Washington, District of Columbia, USA.; Center for Outcomes Research in Liver Diseases, The Global NASH Council, Washington, District of Columbia, USA.
Racila A; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, The Global NASH Council, Washington, District of Columbia, USA.
Nader F; Center for Outcomes Research in Liver Diseases, The Global NASH Council, Washington, District of Columbia, USA.
Henry L; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, The Global NASH Council, Washington, District of Columbia, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 304-312. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Metabolic Syndrome*/diagnosis
Diabetes Mellitus, Type 2*/diagnosis
Humans ; Liver/pathology ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis.
Autorzy:
Noureddin M; Houston Methodist Hospital and Houston Research Institute, Houston, Texas, USA.
Goodman Z; Inova Fairfax Hospital, Falls Church, Virginia, USA.
Tai D; HistoIndex Pte. Ltd., Singapore, Singapore.
Chng ELK; HistoIndex Pte. Ltd., Singapore, Singapore.
Ren Y; HistoIndex Pte. Ltd., Singapore, Singapore.
Boudes P; Galectin Therapeutics Inc., Norcross, USA.
Shlevin H; Galectin Therapeutics Inc., Norcross, USA.
Garcia-Tsao G; Section of Digestive Diseases, Yale University and CT-VA Healthcare System, New Haven, Connecticut, USA.
Harrison SA; Pinnacle Clinical Research, San Antonio, Texas, USA.
Chalasani NP; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (4), pp. 409-417. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/drug therapy
Hypertension, Portal*/etiology
Hypertension, Portal*/complications
Varicose Veins*/complications
Humans ; Liver/pathology ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Fibrosis ; Portal Pressure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systematic review: the role of frailty in advanced chronic liver disease.
Autorzy:
Bowers SP; NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK.; Department of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Brennan PN; Department of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.
Dillon JF; NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK.; Department of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 280-289. Date of Electronic Publication: 2022 Nov 25.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Frailty*/diagnosis
Frailty*/epidemiology
Liver Diseases*
Liver Transplantation*
Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/surgery ; Cohort Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease.
Autorzy:
Chun HS; Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, South Korea.; Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, South Korea.; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Lee M; Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, South Korea.; Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, South Korea.
Lee JS; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Lee HW; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Kim BK; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Park JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Kim DY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Ahn SH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Lee YH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, South Korea.
Kim JH; Department of Health Promotion, Yonsei University Health System, Seoul, South Korea.
Kim SU; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Mar; Vol. 43 (3), pp. 608-625. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*
Cardiovascular Diseases*
Humans ; Risk Factors ; Heart Disease Risk Factors ; Aspartate Aminotransferases ; Liver Cirrhosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The role of the circadian clock in the development, progression, and treatment of non-alcoholic fatty liver disease.
Autorzy:
de Assis LVM; Institute of Neurobiology, Center of Brain Behavior & Metabolism, University of Lübeck, Lübeck, Germany.
Demir M; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
Oster H; Institute of Neurobiology, Center of Brain Behavior & Metabolism, University of Lübeck, Lübeck, Germany.
Pokaż więcej
Źródło:
Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2023 Mar; Vol. 237 (3), pp. e13915. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/metabolism
Circadian Clocks*/physiology
Humans ; Liver/metabolism ; Circadian Rhythm/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Circadian rhythms and the liver.
Autorzy:
Costa R; Institute of Neuroscience, National Research Council (CNR), Padova, Italy.; Department of Biology, University of Padova, Padova, Italy.; Chronobiology Section, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Mangini C; Department of Medicine, University of Padova, Padova, Italy.
Domenie ED; Department of Medicine, University of Padova, Padova, Italy.
Zarantonello L; Department of Medicine, University of Padova, Padova, Italy.
Montagnese S; Chronobiology Section, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.; Department of Medicine, University of Padova, Padova, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Mar; Vol. 43 (3), pp. 534-545. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Circadian Rhythm*/physiology
Liver Diseases*/metabolism
Animals ; Humans ; Liver/metabolism ; Mammals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
Autorzy:
Zhang J; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Laboratory of Liver Diseases, Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shang D; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Laboratory of Liver Diseases, Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Laboratory of Liver Diseases, Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiang X; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Translational Laboratory of Liver Diseases, Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Mar; Vol. 43 (3), pp. 735-736. Date of Electronic Publication: 2023 Jan 06.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Liver*/pathology
Liver Diseases*/pathology
Humans ; Inflammation/pathology ; Liver Cirrhosis/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High plasma levels of betaine, a trimethylamine N-Oxide-related metabolite, are associated with the severity of cirrhosis.
Autorzy:
van den Berg EH; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Flores-Guerrero JL; Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Garcia E; Laboratory Corporation of America Holdings (Labcorp), Morrisville, North Carolina, USA.
Connelly MA; Laboratory Corporation of America Holdings (Labcorp), Morrisville, North Carolina, USA.
de Meijer VE; Department of Hepatopancreatobiliary Surgery and Liver Transplantation, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
Bakker SJL; Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Blokzijl H; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Dullaart RPF; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Pokaż więcej
Corporate Authors:
TransplantLines Investigators
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Feb; Vol. 43 (2), pp. 424-433. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Clinical Study; Journal Article
MeSH Terms:
Betaine*/metabolism
End Stage Liver Disease*
Humans ; Biomarkers ; Cohort Studies ; Liver Cirrhosis ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis.
Autorzy:
Song Y; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Li C; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Luo Y; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Guo J; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Kang Y; Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yin F; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Ye L; Department of Pathology, Shijiazhuang Fifth Hospital, Shijiazhuang, China.
Sun D; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yu J; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhang X; Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Feb; Vol. 43 (2), pp. 357-369. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/pathology
CCN Intercellular Signaling Proteins*/genetics
Animals ; Humans ; Mice ; Diet ; Disease Models, Animal ; Inflammation/pathology ; Liver/pathology ; Liver Cirrhosis/complications ; Methionine/metabolism ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liver stiffness (Fibroscan®) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease.
Autorzy:
Braude M; Gastroenterology and Hepatology, Monash Health, Clayton, Victoria, Australia.; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Roberts S; Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.; Monash Central Clinical School, Monash University, Clayton, Victoria, Australia.
Majeed A; Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.; Monash Central Clinical School, Monash University, Clayton, Victoria, Australia.
Lubel J; Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.; Monash Central Clinical School, Monash University, Clayton, Victoria, Australia.
Prompen J; Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.
Dev A; Gastroenterology and Hepatology, Monash Health, Clayton, Victoria, Australia.; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Sievert W; Gastroenterology and Hepatology, Monash Health, Clayton, Victoria, Australia.; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Bloom S; Monash Central Clinical School, Monash University, Clayton, Victoria, Australia.; Gastroenterology and Hepatology, Eastern Health, Box Hill, Victoria, Australia.
Gow P; Gastroenterology, Austin Health, Heidelberg, Victoria, Australia.; Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
Kemp W; Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.; Monash Central Clinical School, Monash University, Clayton, Victoria, Australia.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Jan; Vol. 43 (1), pp. 90-99. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Liver Cirrhosis/complications ; Liver/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ampicillin exacerbates acetaminophen-induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction.
Autorzy:
Li ZM; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Kong CY; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Mao YQ; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Huang JT; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Chen HL; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Han B; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Wang LS; Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China.; Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Apr; Vol. 43 (4), pp. 865-877. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gastrointestinal Microbiome*
Chemical and Drug Induced Liver Injury*/etiology
Animals ; Mice ; Acetaminophen/toxicity ; Butyrates/pharmacology ; Liver ; Ampicillin/adverse effects ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 86131

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies